Stephen Liu talks through the latest findings from the ARROW trial of pralsetinib for patients with RET fusion-positive advanced non-small-cell lung cancer (3:18).
05-06-2021 | ASCO 2021 | Conference coverage | Video
05-06-2021 | ASCO 2021 | Conference coverage | Video
Stephen Liu talks through the latest findings from the ARROW trial of pralsetinib for patients with RET fusion-positive advanced non-small-cell lung cancer (3:18).